Drugs of Abuse Testing Assays
6-Acetylmorphine
AB-PINACA
- ARK AB-PINACA Assay
- Immunalysis Synthetic Cannabinoids-3 HEIA
Amphetamines
- Immunalysis Amphetamines HEIA
Barbiturates
- Immunalysis Barbiturates HEIA
Benzodiazepines
Benzoylecgonine (Cocaine Metab.)
- Immunalysis Benzoylecgonine HEIA
Buprenorphine
Cannabinoids
- Immunalysis Cannabinoids HEIA
Carisoprodol
- Immunalysis Carisoprodol HEIA
EDDP
- ARK EDDP Assay
- Immunalysis EDDP Specific HEIA
Ethylglucuronide (EtG)
Fentanyl
JWH-018
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-1 HEIA
Ketamine
Meperidine
- ARK Meperidine Assay
- Immunalysis Meperidine HEIA
Methamphetamine
- Immunalysis Methamphetamine HEIA
Methylphenidate-Metabolite
Opiates
- Immunalysis Opiates HEIA
Oxycodone
- Immunalysis Oxycodone HEIA
Phencyclidine (PCP)
- Immunalysis Phencyclidine HEIA
Pregabalin
Tapentadol
- Immunalysis Tapentadol HEIA
Tramadol
- ARK Diagnostics Tramadol Assay
- Immunalysis Tramadol HEIA
UR-144 / XLR-11
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-2 HEIA
Zolpidem
- Immunalysis Zolpidem HEIA
SEFRIA™ Fentanyl Assay
As the first enzyme immunoassay of its kind, the SEFRIA™ Fentanyl Assay utilizes both synthetic and recombinant enzyme fragments of beta-galactosidase for superb sensitivity and vastly improved analysis. With its extremely low cut-off, this assay is ideal for monitoring transdermal patches and transmucosal fentanyl citrate lozenges.
The SEFRIA Fentanyl Assay is an effective screening tool for both monitoring compliance and detecting fentanyl abuse.
Assay Characteristics
- Cut-off as low as 1 ng/mL leads to fewer false-negative results
- Excellent separation between controls and calibrators
- No cross-reactivity with norfentanyl
- Liquid-stable, ready-to-use reagents, calibrators, and controls
- Application protocols for all major clinical chemistry analyzers
- Packaging tailored to your laboratory’s unique needs
Background
Fentanyl was first synthesized in the late 1950s and has proven to be significantly more effective than conventional opioids such as morphine or pethidine (meperidine). The potent synthetic opioid analgesic was introduced as a widely used palliative agent, mainly in the form of transdermal patches and other fast-acting dosage forms for the treatment of chronic pain, particularly in cancer patients.
Since the mid-1970s, fentanyl has also been used as a recreational drug. It appears to have a similar effect to heroin but with a more substantial sedative effect. Due to its short duration of action, there is a high risk of addiction. Fentanyl is available on the illegal market in various forms.
Package Inserts